The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis

por Verhelst, Johan, Mattsson, Anders F, Camacho-Hübner, Cecilia, Luger, Anton, Abs, Roger
Publicado 2018

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant

por Strasburger, Christian J, Mattsson, Anders, Wilton, Patrick, Aydin, Ferah, Hey-Hadavi, Judith, Biller, Beverly M K
Publicado 2018

Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement Therapy: A long-term observational study

por Luger, Anton, Mattsson, Anders F., KoŁtowska-Häggström, Maria, Thunander, Maria, Góth, Miklos, Verhelst, Johan, Abs, Roger
Publicado 2012

SAT-444 Pituitary Function and the Response to GH Replacement Therapy in Patients with Histiocytosis: Analysis of the Pfizer International Metabolic Database (KIMS)

por Touraine, Philippe, Mattsson, Anders, Burman, Pia, Van Beek, Andre, Aydin, Ferah, Kelepouris, Nicky, Feldt-Rasmussen, Ulla, Camacho-Hubner, Cecilia
Publicado 2019

Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database

por Touraine, Philippe, Sagna, Yempabou, Mattsson, Anders F, Burman, Pia, Van Beek, André P, Carlsson, Martin Ove, Aydin, Ferah, Feldt-Rasmussen, Ulla, Camacho-Hübner, Cecilia
Publicado 2022

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

por Johannsson, Gudmundur, Touraine, Philippe, Feldt-Rasmussen, Ulla, Pico, Antonio, Vila, Greisa, Mattsson, Anders F, Carlsson, Martin, Korbonits, Márta, van Beek, André P, Wajnrajch, Michael P, Gomez, Roy, Yuen, Kevin C J
Publicado 2022